Atsuyuki Ikeda

Kyoto, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Recurrent Migration of Fish Bone Foreign Bodies into the Intrahepatic Bile Duct After Pancreaticoduodenectomy Identified by DNA Metabarcoding: A Case Report with Pathophysiological Considerations.

Recurrent Migration of Fish Bone Foreign Bodies into the Intrahepatic Bile Duct After Pancreaticoduodenectomy Identified by DNA Metabarcoding: A Case Report with Pathophysiological Considerations.

Journal: Internal medicine (Tokyo, Japan)

Published: August 10, 2026

Atezolizumab plus Bevacizumab versus Lenvatinib as First-Line Treatment for Unresectable Hepatocellular Carcinoma Stratified by the CRAFITY Score: An International Multicenter Study.

Atezolizumab plus Bevacizumab versus Lenvatinib as First-Line Treatment for Unresectable Hepatocellular Carcinoma Stratified by the CRAFITY Score: An International Multicenter Study.

Journal: Liver cancer

Published: February 06, 2026

Timing of Oral Intake After Colorectal Endoscopic Submucosal Dissection: A Propensity Score-Matched Study.

Timing of Oral Intake After Colorectal Endoscopic Submucosal Dissection: A Propensity Score-Matched Study.

Journal: Digestive diseases and sciences

Published: November 01, 2025

Lenvatinib Versus Atezolizumab Plus Bevacizumab as First-Line Treatment for Advanced Hepatocellular Carcinoma With a CRAFITY Score of 2: A Multi-Center Retrospective Study.

Lenvatinib Versus Atezolizumab Plus Bevacizumab as First-Line Treatment for Advanced Hepatocellular Carcinoma With a CRAFITY Score of 2: A Multi-Center Retrospective Study.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: June 20, 2025

Publisher Correction: CRAFITY score as a predictive marker for refractoriness to atezolizumab plus bevacizumab therapy in hepatocellular carcinoma: a multicenter retrospective study.

Publisher Correction: CRAFITY score as a predictive marker for refractoriness to atezolizumab plus bevacizumab therapy in hepatocellular carcinoma: a multicenter retrospective study.

Journal: Journal of gastroenterology

Published: October 21, 2024

CRAFITY score as a predictive marker for refractoriness to atezolizumab plus bevacizumab therapy in hepatocellular carcinoma: a multicenter retrospective study.

CRAFITY score as a predictive marker for refractoriness to atezolizumab plus bevacizumab therapy in hepatocellular carcinoma: a multicenter retrospective study.

Journal: Journal of gastroenterology

Published: June 05, 2024

A case of autopsy-confirmed duodenal perforation due to calcium polystyrene sulfonate

A case of autopsy-confirmed duodenal perforation due to calcium polystyrene sulfonate

Journal: Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology

Published: February 12, 2023

Sorafenib Rechallenge and Sorafenib after Lenvatinib Failure in a Patient with Hepatocellular Carcinoma.

Sorafenib Rechallenge and Sorafenib after Lenvatinib Failure in a Patient with Hepatocellular Carcinoma.

Journal: Internal medicine (Tokyo, Japan)

Published: February 01, 2021

A fat containing combined neuroendocrine carcinoma and hepatocellular carcinoma in the liver: A case report.

A fat containing combined neuroendocrine carcinoma and hepatocellular carcinoma in the liver: A case report.

Journal: Annals of hepatology

Published: December 05, 2019

Successful biliary drainage by percutaneous transhepatic puncture common bile duct and rendezvous technique for a case of recurrent biliary pancreatitis with a Roux-en-Y reconstruction and without extension of the bile duct

Successful biliary drainage by percutaneous transhepatic puncture common bile duct and rendezvous technique for a case of recurrent biliary pancreatitis with a Roux-en-Y reconstruction and without extension of the bile duct

Journal: Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology

Published: September 13, 2019

A case of relapsed hemosuccus pancreaticus successfully treated with interventional radiology

A case of relapsed hemosuccus pancreaticus successfully treated with interventional radiology

Journal: Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology

Published: September 11, 2018

Hepatitis C Treatment with Sofosbuvir and Ledipasvir Accompanied by Immediate Improvement in Hemoglobin A1c.

Hepatitis C Treatment with Sofosbuvir and Ledipasvir Accompanied by Immediate Improvement in Hemoglobin A1c.

Journal: Digestion

Published: July 28, 2017

Showing 1-12 of 19

Last Updated: 09/26/2026